Cervical myelopathy is a progressive neurological condition arising from compression of the spinal cord in the cervical spine. The most prevalent form, degenerative cervical myelopathy (DCM), results from age-related changes such as intervertebral disc degeneration, ligamentous hypertrophy or ossification, osteophyte formation, and congenital or acquired spinal canal stenosis. It is the leading cause of spinal cord dysfunction in adults worldwide. Though the onset is often insidious, the clinical course varies; some individuals experience a gradual stepwise decline, while others remain stable for prolonged periods. However, even patients who appear stable may experience sudden deterioration. Therefore, ongoing monitoring is essential.
The condition most commonly presents in men, and age of onset is typically late 50s to early 60s. It predominantly affects the C5-C6 level of the spinal cord, followed by C6-C7 and C4-C5. The pathophysiology includes both static compression and dynamic stress during cervical movement, which contribute to vascular insufficiency, inflammation, and neural tissue injury.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreAn increasing number of pregnant patients are seeking advice from their GP about prenatal genetic testing. This FastTrack covers non-invasive prenatal testing/screening, including how it works, indications, limitations, and different types of testing panels. 30mins each of RP and EA CPD available.
Reproductive genetic carrier screening (RGCS) may be considered for patients during their preconception counselling stage. This FastTrack covers who should be offered RGCS, which conditions it screens for, and what to do with the results. 30mins each of RP and EA CPD available.
Menopause can be associated with a significant impact on quality of life as well as long-term risks such as osteoporosis and cardiovascular disease. This FastTrack fact sheet will refresh your knowledge about the diagnosis of menopause and options for management, including menopausal hormone therapy. 30mins each of RP and EA CPD available with the quiz.